We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B Turnover 41.06%
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
-$54.5M
Cap. Flow
+$154M
Cap. Flow %
10.62%
Top 10 Hldgs %
43.38%
Holding
129
New
42
Increased
32
Reduced
24
Closed
24
Avg Time Held Equity + Options
0.6 years
Top 10 Avg Time Held Equity + Options
0.6 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.6 years
Top 20 Avg Time Held Equity only
0.9 years

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$37.6M
2
CYH icon
Community Health Systems
CYH
+$28.3M
3
ASND icon
Ascendis Pharma A/S
ASND
+$27.8M
4
CTLT icon
CATALENT, INC.
CTLT
+$23M
5
MASI icon
Masimo
MASI
+$18.2M

Top Sells

Rank Stock Value
1
QGEN icon
Qiagen
QGEN
+$26.7M
2
AMRN icon
Amarin Corp
AMRN
+$24.9M
3
OGN icon
Organon & Co
OGN
+$21.2M
4
DHR icon
Danaher
DHR
+$17.4M
5
AMN icon
AMN Healthcare
AMN
+$15.8M

Sector Composition

Rank Sector Weight
1 Healthcare 80.74%
2 Miscellaneous 17.65%
3 Industrials 1.16%
4 Financials 0.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AZN icon
26
CALL
AstraZeneca
AZN
$257B
$15.6M 1.08%
+130,150
New +$15.2M
2021 Q3
0 quarters
FATE icon
27
Fate Therapeutics
FATE
$214M
$15.5M 1.07%
260,895
-85,452
-25% -$6.7M
2018 Q4
11 quarters
GSK icon
28
GSK
GSK
$99.2B
$15.4M 1.07%
321,323
+231,180
+256% +$11.6M
2018 Q1
14 quarters
IONS icon
29
Ionis Pharmaceuticals
IONS
$7.14B
$15.1M 1.05%
450,501
+8,501
+2% +$320K
2021 Q2
1 quarter
CYH icon
30
CALL
Community Health Systems
CYH
$406M
$12.6M 0.87%
+1,077,200
New +$14.1M
2021 Q3
0 quarters
GH icon
31
Guardant Health
GH
$21.3B
$12.5M 0.87%
100,361
+98,552
+5,448% +$11.7M
2021 Q1
2 quarters
NTRA icon
32
Natera
NTRA
$56.7B
$12.5M 0.86%
112,189
+102,875
+1,105% +$11.8M
2021 Q1
2 quarters
SNY icon
33
Sanofi
SNY
$97.3B
$12.5M 0.86%
+259,128
New +$13.2M
2021 Q3
0 quarters
ELV icon
34
Elevance Health
ELV
$92.9B
$11.8M 0.82%
31,628
+21,496
+212% +$8.17M
2020 Q4
3 quarters
ZGNX
35
DELISTED
Zogenix, Inc.
ZGNX
$11.8M 0.81%
774,591
+278,731
+56% +$4.35M
2017 Q4
15 quarters
TARO icon
36
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$11.4M 0.79%
179,366
+5,117
+3% +$354K
2019 Q4
7 quarters
ALNY icon
37
Alnylam Pharmaceuticals
ALNY
$31B
$11.2M 0.77%
59,233
+8,097
+16% +$1.52M
2021 Q1
2 quarters
EXEL icon
38
Exelixis
EXEL
$15.4B
$10.9M 0.75%
516,307
+336,307
+187% +$6.25M
2021 Q2
1 quarter
MGLN
39
DELISTED
Magellan Health Services, Inc.
MGLN
$9.9M 0.68%
104,700
– –
2020 Q4
3 quarters
HUM icon
40
Humana
HUM
$49.6B
$9.39M 0.65%
24,083
+5,427
+29% +$2.3M
2021 Q1
2 quarters
TEVA icon
41
CALL
Teva Pharmaceutical Industries Limited
TEVA
$48.4B
$9.37M 0.65%
962,400
+769,500
+399% +$7.21M
2021 Q2
1 quarter
HCA icon
42
HCA Healthcare
HCA
$99.3B
$9.31M 0.64%
38,366
+30,052
+361% +$7.35M
2020 Q1
6 quarters
CNC icon
43
Centene
CNC
$34.2B
$8.79M 0.61%
141,107
+73,107
+108% +$4.88M
2021 Q1
2 quarters
ITCI icon
44
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$8.6M 0.6%
230,744
+113,282
+96% +$3.94M
2020 Q3
4 quarters
RVTY icon
45
Revvity
RVTY
$17B
$8.16M 0.56%
+47,081
New +$8.3M
2021 Q3
0 quarters
NSTG
46
DELISTED
NanoString Technologies, Inc.
NSTG
$8.1M 0.56%
+168,668
New +$9.7M
2021 Q3
0 quarters
HZNP
47
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$7.67M 0.53%
70,000
– –
2021 Q2
1 quarter
HQY icon
48
HealthEquity
HQY
$7.61B
$7.41M 0.51%
114,378
-83,122
-42% -$5.77M
2021 Q2
1 quarter
QGEN icon
49
Qiagen
QGEN
$9.53B
$7.4M 0.51%
134,960
-479,002
-78% -$26.7M
2020 Q2
5 quarters
IRTC icon
50
iRhythm Holdings
IRTC
$3.58B
$6.67M 0.46%
+113,854
New +$6.03M
2021 Q3
0 quarters
1
2
3 4 5

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

Eversept Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Eversept Partners held 129 positions worth $1.45B, down 3.6% from $1.5B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Eversept Partners deployed $154M of net new capital in Q3 2021, opening 42 new positions and adding to 32 existing holdings. Its largest new stake was Labcorp: 149,354 shares worth $36.1M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, up from 65% a quarter earlier, followed by Miscellaneous and Industrials.

On the sell side, the largest reduction was Qiagen, an estimated $26.7M trimmed.

  • Eversept Partners's largest Q3 2021 buy was Labcorp: 149,354 shares worth $36.1M.
  • Eversept Partners added most to Community Health Systems in Q3 2021, an estimated $28.3M increase.
  • Eversept Partners's biggest Q3 2021 reduction was Qiagen, cutting an estimated $26.7M.
  • Eversept Partners fully exited Organon & Co in Q3 2021, selling an estimated $21.2M.
  • Eversept Partners's ten largest holdings make up 43% of its $1.45B portfolio in Q3 2021.
  • Eversept Partners opened 42 new positions and closed 24 in Q3 2021.
  • Eversept Partners's portfolio value fell 3.6% quarter-over-quarter to $1.45B.

Based on Eversept Partners's 13F filing for Q3 2021, filed 15 Nov 2021.